Wilbe Capital

Overview

Wilbe Capital is a venture capital firm headquartered in London, England, dedicated to supporting scientist-led startups that are addressing some of the world's most pressing challenges. The firm focuses on providing funding and resources to early-stage companies in sectors such as material science, energy, biotechnology, and medical research. By partnering with scientists and engineers, Wilbe Capital aims to accelerate the commercialization of groundbreaking research and innovation. The firm's investment strategy centers on identifying and nurturing ventures that have the potential to make a significant societal impact. Wilbe Capital typically invests in pre-seed and seed-stage companies, offering financial support ranging from $100,000 to $250,000. This approach enables the firm to assist in the early development and scaling of innovative solutions across various industries, including energy, biotechnology, and medical therapeutics. Wilbe Capital's portfolio includes a diverse array of companies, such as Apoha, which is developing advanced material science technologies; Proxima Fusion, focused on energy and nuclear science innovations; and ExpressionEdits, working on breakthroughs in biotechnology. The firm's commitment to fostering innovation is further exemplified by its subsidiary, WilbeLAB, which partners with science ventures and property owners to transform spaces into fully operational science labs and innovation hubs, providing comprehensive management of lab and office spaces to support the growth of science ventures.

Investment Focus

• Scientist-led startups addressing global challenges
• Early-stage companies in material science, energy, biotechnology, and medical research
• Pre-seed and seed-stage ventures seeking funding between $100,000 and $250,000

Portfolio Companies